Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Cost of Revenue (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Cost of Revenue data on record, last reported at $241.3 million in Q4 2025.

  • For Q4 2025, Cost of Revenue rose 16.33% year-over-year to $241.3 million; the TTM value through Dec 2025 reached $997.3 million, up 32.28%, while the annual FY2025 figure was $896.3 million, 27.21% up from the prior year.
  • Cost of Revenue reached $241.3 million in Q4 2025 per PAHC's latest filing, down from $244.1 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $268.7 million in Q2 2025 and bottomed at $142.6 million in Q1 2021.
  • Average Cost of Revenue over 5 years is $185.8 million, with a median of $174.1 million recorded in 2022.
  • Peak YoY movement for Cost of Revenue: fell 0.15% in 2023, then skyrocketed 44.45% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $162.0 million in 2021, then increased by 3.22% to $167.3 million in 2022, then rose by 2.43% to $171.3 million in 2023, then increased by 21.05% to $207.4 million in 2024, then rose by 16.33% to $241.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $241.3 million in Q4 2025, $244.1 million in Q3 2025, and $268.7 million in Q2 2025.